Dana Goldner, MD, is an Assistant Professor of Pediatrics in Pediatric Hepatology at Columbia University Medical Center and an Assistant Attending at NewYork-Presbyterian Morgan Stanley Children’s Hospital. Prior to her faculty appointment, Dr. Goldner earned her Bachelor of Science degree in Molecular Biology from the Massachusetts Institute of Technology (MIT). She completed her medical education at Weill Cornell Medical College/NewYork-Presbyterian and subsequently completed her Pediatric Internship and Residency at Massachusetts General Hospital/Harvard Medical School in Boston. She then went on to pursue fellowships in both Pediatric Gastroenterology, Hepatology and Nutrition and Pediatric Transplant Hepatology at New York Presbyterian/Columbia University Medical Center.
Dr. Goldner is triple board certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology. Her clinical and research interests include acute liver failure, metabolic and genetic liver disease, biliary atresia, Alpha-1 antitrypsin deficiency, liver masses, and transplant hepatology.
About Dana Goldner
Medical School: Cornell University, Joan & Sanford I. Weill Medical College
Graduation Year: 2009
Professional Webpage: https://www.pediatrics.columbia.edu/profile/dana-l-goldner-m...
Honors and Awards:
Top Doctors New York Metro Area 2019, 2020, 2021
Castle Connolly Exceptional Women In Medicine: 2019, 2020
New York Magazine: Top Doctors: 2021
2016 – present ABP: Board Certified in Pediatric Transplant Hepatology
2015 - present ABP: Board Certified in Pediatric Gastroenterology
2012 – present ABP: Board Certified in Pediatrics
2018- present, Reviewer for Pediatrics and Journal of Pediatric Gastroenterology and Nutrition
2015-present Membership Working Group, Pediatric Special Interest Group, American Association for the Study of Liver Diseases
2012-present North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Member
Publications, Lectures and Presentations:
Kang E, Shin JI, Griesemer AD, Lobritto S, Goldner D, Vittorio JM, Stylianos S, Martinez M. Risk Factors for 30-Day Unplanned Readmission After Hepatectomy: Analysis of 438 Pediatric Patients from the ACS-NSQIP-P Database. J Gastrointest Surg. 2021 Apr 6.
Chen J, Salerno D, Breslin N, Chowdhury T, Lobritto S, Martinez M, Goldner D, Vittorio J. Concomitant tacrolimus and ketorolac therapy in pediatric liver transplant recipients: Teaching old dogma new tricks. Clin Transplant. 2021 Jan;35(1):e14141. doi: 10.1111/ctr.14141. Epub 2020 Nov 19. PMID: 33145821.
Heinz N, Griesemer A, Kinney J, Vittorio J, Lagana SM, Goldner D, Velasco M, Kato T, Lobritto S, Martinez M. A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation. Pediatr Transplant. 2020 Dec;24(8):e13778. doi: 10.1111/petr.13778. Epub 2020 Jun 25. PMID: 32559354; PMCID: PMC7323125.
Chen J, Ferreira J, Martinez M, Lobritto S, Goldner D, Vittorio J. Role of Budesonide for the Treatment of Rejection in Pediatric Liver Transplantation. J Pediatr Gastroenterol Nutr. 2020 Sep;71(3):388-392. doi: 10.1097/MPG.0000000000002784. PMID: 32404767.
Goldner D, Lavine JE. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. Gastroenterology. 2020 May;158(7):1967-1983.e1. doi: 10.1053/j.gastro.2020.01.048. Epub 2020 Mar 20. PMID: 32201176.
Massachusetts Institute of Technology, BS in Biology
Cornell Medical College, MD
Residency: Massachusetts General Hospital, Pediatrics
Fellowship: NewYork-Presbyterian/Columbia University, Pediatric Gastroenterology, Hepatology, and Nutrition
Fellowship: NewYork-Presbyterian/Columbia University, Advanced Hepatology and Liver Transplant